The Ministry of industry and trade of the Russian Federation
FSI «SID & GP»
+7 (495) 676-43-60 109044, Moscow, Lavrov lane., 6
157 license holders out of 189 manufacturing sites have received a GMP-certificate following the procedure of filing an application
Giuseppe Fedegari: «The shortcut to training: working with people who already have the experience»
On 07 February, a new solids manufacturing facility was launched by the «Obolenskoe» Pharmaceutical Enterprise
A regular educational course for pharmaceutical inspectors is taking place at FSI «SID & GP»

About institute

State Institute of Drugs and Good Practices

The Federal State Institution «State Institute of Drugs and Good Practices» (also known as FSI «SID & GP») is a subordinate agency of the Russian Ministry of Industry and Trade. The Institute was founded in 1973. For more than 40 years, the Institute has been a major research facility in the field of pharmacy.

In 2013, the FSI «SID & GP» received accreditation as an expert organization for licensing control of pharmaceutical manufacturers during inspections conducted by the Russian Ministry of Industry and Trade.

In 2015, FSI «SID & GP» was authorized to conduct GMP inspections of pharmaceutical products for human use produced outside of the Russian Federation, to issue compliance verifications of pharmaceutical manufacturers with the GMP requirements.

The Institute is Headed by Vladislav Shestakov.

Latest news

In Sochi, within the «Healthy Life. On the Way to Target 80+» Forum, a session under the topic «The system of universal health coverage as a key to ac…
In anticipation of the Russian Investment Forum, today, in Sochi, the Healthy Life Forum has been started with its key topic being the system of unive…
Today, a 3-day training workshop for experts of the pharmaceutical inspectorate with international participation has been started. The event has been…
From 12 to 14 February, 2019, the State Institute of Drugs and Good Practices together with the FEDEGARI and the NoDeviation companies will hold a tra…
The amounts of 1.6 billion tablets, 120 million capsules and 15 million sachets will become available for treatment of cardio-vascular, musculoskeleta…
On 04 February, 2019, the State Institute of Drugs and Good Practices started a regular educational course for GMP inspectors (theory and practice) in…
On 06 February, the XI Delovaya Rossiya Forum was held. It was dedicated to the role of business and support in implementation of national goals towar…
At the end of January, FSI «SID & GP» and the Pharmstrategy company held a regular expert-advisory workshop within the joint program of promoting impl…
On 29 January, 2019, representatives of FSI "SID & GP" supported by the Trade Delegation of Russia in the UK met with representatives of the Medicines…
The purpose of the environmental monitoring program is to prove acceptability of the required drug...

Our partners